World

LSD – from counterculture to clinical trials

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 07/10/2026, 18:41:24 UTC.

Briefings

A 2026 article reports LSD's return to the lab following its counterculture history and CIA mind-control experiments. The evidence suggests the drug is being reintroduced to clinical trials, marking a significant shift from its original psychiatric research origins.

Key points

• LSD is being reintroduced to clinical trials after its history in psychiatric research and secret CIA mind-control experiments.
• The article indicates the drug is moving back to the lab, though specific trial details or participant numbers are not provided.

Context

This finding marks a significant shift from the drug's original use in psychiatric research and its history in secret CIA mind-control experiments.

Limitations

The evidence is a single article from 2026 with no specific dates, numbers, or names of participants. It does not specify the duration of the trials or the exact nature of the CIA experiments.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 24/10/2026, 06:23:00 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeifxz4plpuzvsz3nztqpsjjcyr2rrfwc6g73xxwonitigh2xehqmce